Logo image of BNED

BARNES & NOBLE EDUCATION INC (BNED) Stock Fundamental Analysis

NYSE:BNED - US06777U2006 - Common Stock

8.67 USD
+0.14 (+1.64%)
Last: 8/22/2025, 8:04:00 PM
8.88 USD
+0.21 (+2.42%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BNED. BNED was compared to 124 industry peers in the Specialty Retail industry. BNED may be in some trouble as it scores bad on both profitability and health. BNED has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BNED has reported negative net income.
In the past year BNED has reported a negative cash flow from operations.
BNED had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BNED reported negative operating cash flow in multiple years.
BNED Yearly Net Income VS EBIT VS OCF VS FCFBNED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.44%, BNED is doing worse than 70.97% of the companies in the same industry.
BNED's Return On Equity of -24.71% is on the low side compared to the rest of the industry. BNED is outperformed by 61.29% of its industry peers.
With a Return On Invested Capital value of 4.54%, BNED perfoms like the industry average, outperforming 55.65% of the companies in the same industry.
Industry RankSector Rank
ROA -6.44%
ROE -24.71%
ROIC 4.54%
ROA(3y)-7.93%
ROA(5y)-8.13%
ROE(3y)-65.88%
ROE(5y)-50.9%
ROIC(3y)N/A
ROIC(5y)N/A
BNED Yearly ROA, ROE, ROICBNED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BNED has a Operating Margin (2.03%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BNED has declined.
BNED has a Gross Margin of 22.39%. This is in the lower half of the industry: BNED underperforms 76.61% of its industry peers.
BNED's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.03%
PM (TTM) N/A
GM 22.39%
OM growth 3YN/A
OM growth 5Y-30.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.61%
GM growth 5Y-2.57%
BNED Yearly Profit, Operating, Gross MarginsBNED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

3

2. Health

2.1 Basic Checks

BNED has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BNED has been reduced compared to 1 year ago.
The number of shares outstanding for BNED has been reduced compared to 5 years ago.
The debt/assets ratio for BNED is higher compared to a year ago.
BNED Yearly Shares OutstandingBNED Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BNED Yearly Total Debt VS Total AssetsBNED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that BNED is in the distress zone and has some risk of bankruptcy.
BNED has a Altman-Z score of 1.10. This is in the lower half of the industry: BNED underperforms 70.97% of its industry peers.
BNED has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
BNED has a Debt to Equity ratio (0.50) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACC0.4
WACC11.36%
BNED Yearly LT Debt VS Equity VS FCFBNED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BNED has a Current Ratio of 1.42. This is a normal value and indicates that BNED is financially healthy and should not expect problems in meeting its short term obligations.
BNED has a Current ratio of 1.42. This is comparable to the rest of the industry: BNED outperforms 56.45% of its industry peers.
A Quick Ratio of 0.73 indicates that BNED may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.73, BNED is in the better half of the industry, outperforming 62.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.73
BNED Yearly Current Assets VS Current LiabilitesBNED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.43% over the past year.
Looking at the last year, BNED shows a small growth in Revenue. The Revenue has grown by 1.38% in the last year.
Measured over the past years, BNED shows a decrease in Revenue. The Revenue has been decreasing by -5.09% on average per year.
EPS 1Y (TTM)88.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.28%
Revenue 1Y (TTM)1.38%
Revenue growth 3Y3.67%
Revenue growth 5Y-5.09%
Sales Q2Q%2.11%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y91.96%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.43%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BNED Yearly Revenue VS EstimatesBNED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BNED Yearly EPS VS EstimatesBNED Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BNED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BNED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BNED Price Earnings VS Forward Price EarningsBNED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BNED is valued a bit cheaper than the industry average as 78.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.93
BNED Per share dataBNED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BNED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BARNES & NOBLE EDUCATION INC

NYSE:BNED (8/22/2025, 8:04:00 PM)

After market: 8.88 +0.21 (+2.42%)

8.67

+0.14 (+1.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)09-08 2025-09-08
Inst Owners64.76%
Inst Owner Change10.34%
Ins Owners5.71%
Ins Owner Change0.44%
Market Cap295.21M
Analysts43.33
Price TargetN/A
Short Float %7.26%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.52%
Min EPS beat(2)-96.94%
Max EPS beat(2)87.91%
EPS beat(4)3
Avg EPS beat(4)38.91%
Min EPS beat(4)-96.94%
Max EPS beat(4)91.09%
EPS beat(8)4
Avg EPS beat(8)-217.77%
EPS beat(12)4
Avg EPS beat(12)-187.69%
EPS beat(16)5
Avg EPS beat(16)-162.58%
Revenue beat(2)0
Avg Revenue beat(2)-3.74%
Min Revenue beat(2)-5.17%
Max Revenue beat(2)-2.31%
Revenue beat(4)0
Avg Revenue beat(4)-5.02%
Min Revenue beat(4)-8.85%
Max Revenue beat(4)-2.31%
Revenue beat(8)2
Avg Revenue beat(8)-2.99%
Revenue beat(12)3
Avg Revenue beat(12)-2.33%
Revenue beat(16)4
Avg Revenue beat(16)-3.53%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 1.04
P/tB 1.46
EV/EBITDA 5.93
EPS(TTM)-15.5
EYN/A
EPS(NY)-6.29
Fwd EYN/A
FCF(TTM)-2.02
FCFYN/A
OCF(TTM)-1.67
OCFYN/A
SpS46.04
BVpS8.32
TBVpS5.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.44%
ROE -24.71%
ROCE 5.75%
ROIC 4.54%
ROICexc 4.62%
ROICexgc 5.44%
OM 2.03%
PM (TTM) N/A
GM 22.39%
FCFM N/A
ROA(3y)-7.93%
ROA(5y)-8.13%
ROE(3y)-65.88%
ROE(5y)-50.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-34.2%
ROICexc growth 3YN/A
ROICexc growth 5Y-31.19%
OM growth 3YN/A
OM growth 5Y-30.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.61%
GM growth 5Y-2.57%
F-Score5
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA 1.98
Cap/Depr 30.24%
Cap/Sales 0.76%
Interest Coverage 1.61
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.73
Altman-Z 1.1
F-Score5
WACC11.36%
ROIC/WACC0.4
Cap/Depr(3y)57.74%
Cap/Depr(5y)57.66%
Cap/Sales(3y)1.59%
Cap/Sales(5y)1.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.28%
EPS Next Y91.96%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.38%
Revenue growth 3Y3.67%
Revenue growth 5Y-5.09%
Sales Q2Q%2.11%
Revenue Next Year-0.43%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y395.5%
EBIT growth 3YN/A
EBIT growth 5Y-34.29%
EBIT Next Year440.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-21.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.78%
OCF growth 3YN/A
OCF growth 5YN/A